241. Hypertyrosinemia type I
14 clinical trials, 7 drugs (DrugBank: 1 drug), 1 drug target gene, 5 drug target pathways
Searched query = "Hypertyrosinemia type I", "Tyrosinemia type I", "Tyrosinemia I", "Hereditary tyrosinemia, Type I", "Fumarylacetoacetate hydrolase deficiency", "FAH deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00004443 (ClinicalTrials.gov) | October 1998 | 18/10/1999 | Study of NTBC for Tyrosinemia I | Tyrosinemia I | Drug: NTBC | University of Washington | NULL | Completed | N/A | 17 Years | Both | 20 | N/A | United States;Canada | |
| 2 | NCT00004333 (ClinicalTrials.gov) | November 1994 | 18/10/1999 | Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I | Tyrosinemia, Type I | Drug: NTBC | National Center for Research Resources (NCRR) | University of Michigan | Completed | N/A | N/A | Both | Phase 2 | NULL |